Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
5.65
-0.04 (-0.70%)
Sep 8, 2025, 11:27 AM - Market open
SLN's stock price has decreased by -71.12% in the past year and price targets may not have had time to catch up.
Silence Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$32.60
Upside
+476.99%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $35 | Strong Buy | Maintains | $35 | +519.47% | Aug 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +1,227.43% | Jun 13, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $35 | Strong Buy | Maintains | $35 | +519.47% | Jun 13, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $4 → $3 | Strong Sell | Maintains | $4 → $3 | -46.90% | May 9, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $45 → $25 | Buy | Maintains | $45 → $25 | +342.48% | May 9, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $55 → $35 | Strong Buy | Maintains | $55 → $35 | +519.47% | May 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +1,227.43% | Mar 7, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $49 → $45 | Buy | Maintains | $49 → $45 | +696.46% | Mar 5, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $67 → $25 | Buy | Maintains | $67 → $25 | +342.48% | Mar 4, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $6 → $4 | Strong Sell | Maintains | $6 → $4 | -29.20% | Mar 4, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Sell Initiates $6 | Strong Sell | Initiates | $6 | +6.19% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +1,227.43% | Feb 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +1,227.43% | Jan 29, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $55 | Strong Buy | Maintains | $55 | +873.45% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +1,227.43% | Dec 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +1,227.43% | Nov 20, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.